Home › Funds › GREAT LAKES ADVISORS, LLC › ABT

GREAT LAKES ADVISORS, LLC position in ABT

ABBOTT LABORATORIES · Health Care

GREAT LAKES ADVISORS, LLC reported holding 1,366,478 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$135.0M, representing 1.14% of its reported portfolio and ranking #29 among its reported holdings. GREAT LAKES ADVISORS, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.37M sh
Reported value held$135.05M
Portfolio Weight1.14%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GREAT LAKES ADVISORS, LLC's ABT position evolved

GREAT LAKES ADVISORS, LLC first disclosed a stake in ABT in Q3 2023 at 1,316,125 shares (US$127.5M). The position peaked in Q3 2025 at 1,342,628 shares, worth US$179.8M. Across 13 filings, GREAT LAKES ADVISORS, LLC increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,366,478 shares valued at US$135.0M — an increase of 21,595 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.32M $127.47M New
Q4 2023 1.12M $123.42M Reduce
Q1 2024 1.16M $131.37M Add
Q2 2024 1.10M $114.43M Reduce
Q3 2024 1.11M $126.46M Add
Q4 2024 1.13M $127.86M Add
Q1 2025 1.23M $163.52M Add
Q2 2025 1.29M $176.02M Add
Q3 2025 1.34M $179.83M Add
Q4 2025 1.31M $164.48M Reduce
Q1 2026 1.36M $139.55M Add
Q2 2026 1.34M $122.03M Reduce
Q3 2026 1.37M $135.05M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has GREAT LAKES ADVISORS, LLC held ABT?

GREAT LAKES ADVISORS, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is GREAT LAKES ADVISORS, LLC's current position in ABT?

As of Q3 2026, GREAT LAKES ADVISORS, LLC holds 1.37M shares of ABT (ABBOTT LABORATORIES), valued at $135.05M, representing 1.14% of its reported portfolio and ranking #29.

Has GREAT LAKES ADVISORS, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), GREAT LAKES ADVISORS, LLC increased its position in ABT. The position peaked in Q3 2025 at 1.34M shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.